Literature DB >> 29509886

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

Bianca Rocca1, Keith A A Fox2, Ramzi A Ajjan3, Felicita Andreotti4, Colin Baigent5, Jean-Philippe Collet6, Erik L Grove7,8, Sigrun Halvorsen9, Kurt Huber10, João Morais11, Carlo Patrono1, Andrea Rubboli12, Ingebjorg Seljeflot13, Dirk Sibbing14,15, Agneta Siegbahn16, Jurrien Ten Berg17, Gemma Vilahur18, Freek W A Verheugt19, Lars Wallentin20, Thomas W Weiss10, Johann Wojta21,22,23, Robert F Storey24.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29509886     DOI： 10.1093/eurheartj/ehy066

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  Increased bodyweight and inadequate response to aspirin in individuals with coronary artery disease.

Authors:  Remo H M Furtado; Robert P Giugliano; Talia F Dalcoquio; Flavia B B Arantes; Carlos J D G Barbosa; Paulo R R Genestreti; André Franci; Fernando R Menezes; Carlos A K Nakashima; Marco A Scanavini Filho; Aline G Ferrari; Rocio Salsoso; Luciano M Baracioli; Jose C Nicolau
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

2.  Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Francesco Tonon; Elvin Kedhi; Harry Suryapranata; Alessandro Carriero; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

Review 3.  Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.

Authors:  Michael J Jamieson; Wonkyung Byon; Richard W Dettloff; Matthew Crawford; Peter S Gargalovic; Samira J Merali; Joelle Onorato; Andres J Quintero; Cristina Russ
Journal:  Am J Cardiovasc Drugs       Date:  2022-05-16       Impact factor: 3.571

4.  Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

Authors:  João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia
Journal:  Rev Bras Ter Intensiva       Date:  2022-01-24

Review 5.  The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach.

Authors:  Zlatko Fras; Amirhossein Sahebkar; Maciej Banach
Journal:  Am J Cardiovasc Drugs       Date:  2021-03       Impact factor: 3.571

Review 6.  Role of aspirin in primary prevention of cardiovascular disease.

Authors:  Carlo Patrono; Colin Baigent
Journal:  Nat Rev Cardiol       Date:  2019-06-26       Impact factor: 32.419

7.  The Characteristics and Clinical Outcomes of Direct Oral Anticoagulantsin Patients with Atrial Fibrillation and Chronic Kidney Disease: From the Database of A Single-Center Registry.

Authors:  Takao Sato; Yoshifusa Aizawa; Hitoshi Kitazawa; Masaaki Okabe
Journal:  J Atr Fibrillation       Date:  2020-08-31

8.  Antithrombotic therapy in diabetes: which, when, and for how long?

Authors:  Ramzi A Ajjan; Noppadol Kietsiriroje; Lina Badimon; Gemma Vilahur; Diana A Gorog; Dominick J Angiolillo; David A Russell; Bianca Rocca; Robert F Storey
Journal:  Eur Heart J       Date:  2021-06-14       Impact factor: 29.983

Review 9.  Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.

Authors:  Sophie Susen; Charles Ambroise Tacquard; Alexandre Godon; Alexandre Mansour; Delphine Garrigue; Philippe Nguyen; Anne Godier; Sophie Testa; Jerrold H Levy; Pierre Albaladejo; Yves Gruel
Journal:  Crit Care       Date:  2020-06-19       Impact factor: 9.097

Review 10.  Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart.

Authors:  Gemma Vilahur; Phuong Hue Nguyen; Lina Badimon
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-12       Impact factor: 3.947
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.